Molecular Pathology: Unraveling Breast Cancer Subtypes

This track focuses on the latest advancements in molecular pathology techniques and their application in unraveling the intricate subtypes of breast cancer. With the advent of genomic profiling and molecular markers, this session aims to explore the diverse molecular landscapes that underlie breast cancer, including hormone receptor-positive, HER2-positive, and triple-negative subtypes. Experts will discuss the molecular signatures, genomic alterations, and gene expression profiles associated with these subtypes, enabling a deeper understanding of their unique characteristics and implications for prognosis and treatment. Attendees will gain insights into the evolving field of molecular pathology, its impact on breast cancer classification, and the potential for personalized therapeutic interventions.

  • Genomic Profiling of Breast Cancer: Uncovering Molecular Alterations
  • Transcriptomic Signatures in Breast Cancer: Gene Expression Profiling
  • Epigenetic Modifications and Breast Cancer Subtypes
  • Signaling Pathways and Molecular Subtypes of Breast Cancer
  • Emerging Technologies in Molecular Pathology: Advancements in Breast Cancer Subtyping

Related Conference of Molecular Pathology: Unraveling Breast Cancer Subtypes

June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 24-25, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada

Molecular Pathology: Unraveling Breast Cancer Subtypes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in